Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HF0220 in Mild to Moderate Alzheimer's Disease
NCT00357357Phase 2Completed
- Sponsor
- Hunter-Fleming
- Start
- Jul 2006
- Primary completion
- Aug 2008
- Countries
- 3
01
Overview
A Phase 2 trial of 7-beta-hydroxyepiandrosterone in Alzheimer's disease (AD), sponsored by Hunter-Fleming. Started Jul 2006; status: completed.
02
Drugs
7-beta-hydroxyepiandrosterone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00357357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357357.